<DOC>
	<DOCNO>NCT02307409</DOCNO>
	<brief_summary>This study attempt clarify pathophysiology haemostasis haematopoiesis relation evidence sepsis liver disease , compare accuracy various available laboratory test assessment patient . Further research need proper understanding influence sepsis coagulation disorder ACLF ( Acute Chronic Liver Failure ) patient particular , correctly identify type optimal quantity blood product requirement risk patient . Thromboelastography ( TEG ) /Sonoclot propose superior tool rapidly diagnose help guide resuscitation blood product . Secondly , study derangement coagulopathy onset sepsis paramount importance increase mortality onset sepsis . In present study , patient ACLF ( Acute Chronic Liver Failure ) without evidence sepsis admission include study cohort , undergo baseline diagnostic workup describe . They follow development sign infection hospitalization . Then effect sepsis coagulation haematopoietic cellular response assess . Thus effect sepsis progression outcome patient ACLF ( Acute Chronic Liver Failure ) study .</brief_summary>
	<brief_title>Assessment Coagulation Profile Haematopoietic Responses Patients With Acute-on-chronic Liver Failure During Systemic Inflammatory Response ( SIRS ) Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<criteria>Age 1865 year ACLF ( Acute Chronic Liver Failure ) , diagnose APASL ( Asian Pacific association Study Liver Disease ) criterion mention . Patients evidence sepsis presentation . Current therapy : Recent blood blood component transfusion last 2 day . HIV positive/ AIDS patient Patients require anti platelet therapy , Renal insufficiency require dialysis Active malignancy within last 5 year Patient neurological disease metabolic disorder , unbalanced heart failure and/or respiratory failure endstage renal disease Administration anticoagulant , antifibrinolytics , Not willing participate study Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>